These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 16424797

  • 1. Inhibitory effect of efonidipine on aldosterone synthesis and secretion in human adrenocarcinoma (H295R) cells.
    Imagawa K, Okayama S, Takaoka M, Kawata H, Naya N, Nakajima T, Horii M, Uemura S, Saito Y.
    J Cardiovasc Pharmacol; 2006 Jan; 47(1):133-8. PubMed ID: 16424797
    [Abstract] [Full Text] [Related]

  • 2. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O, Inayoshi A, Kitayama T, Yao K, Shirakura S, Sasaki K, Kusaka H, Matsubara M.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):424-34. PubMed ID: 18331727
    [Abstract] [Full Text] [Related]

  • 3. Azelnidipine inhibits aldosterone synthesis and secretion in human adrenocortical cell line NCI-H295R.
    Isaka T, Ikeda K, Takada Y, Inada Y, Tojo K, Tajima N.
    Eur J Pharmacol; 2009 Mar 01; 605(1-3):49-52. PubMed ID: 19168055
    [Abstract] [Full Text] [Related]

  • 4. Blocking T-type Ca2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers.
    Okayama S, Imagawa K, Naya N, Iwama H, Somekawa S, Kawata H, Horii M, Nakajima T, Uemura S, Saito Y.
    Hypertens Res; 2006 Jul 01; 29(7):493-7. PubMed ID: 17044661
    [Abstract] [Full Text] [Related]

  • 5. Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms.
    Lee TS, Kaku T, Takebayashi S, Uchino T, Miyamoto S, Hadama T, Perez-Reyes E, Ono K.
    Pharmacology; 2006 Jul 01; 78(1):11-20. PubMed ID: 16899990
    [Abstract] [Full Text] [Related]

  • 6. Efonidipine, a Ca(2+)-channel blocker, enhances the production of dehydroepiandrosterone sulfate in NCI-H295R human adrenocortical carcinoma cells.
    Ikeda K, Saito T, Tojo K.
    Tohoku J Exp Med; 2011 Aug 01; 224(4):263-71. PubMed ID: 21757861
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A selective T-type Ca2+ channel blocker R(-) efonidipine.
    Shin MC, Kim CJ, Min BI, Ogawa S, Tanaka E, Akaike N.
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun 01; 377(4-6):411-21. PubMed ID: 18278483
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The R(-)-enantiomer of efonidipine blocks T-type but not L-type calcium current in guinea pig ventricular myocardium.
    Tanaka H, Komikado C, Shimada H, Takeda K, Namekata I, Kawanishi T, Shigenobu K.
    J Pharmacol Sci; 2004 Dec 01; 96(4):499-501. PubMed ID: 15599089
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of N-type calcium channels in human adrenocortical cells and their contribution to corticosteroid synthesis.
    Aritomi S, Wagatsuma H, Numata T, Uriu Y, Nogi Y, Mitsui A, Konda T, Mori Y, Yoshimura M.
    Hypertens Res; 2011 Feb 01; 34(2):193-201. PubMed ID: 20981032
    [Abstract] [Full Text] [Related]

  • 13. Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy.
    Sasaki H, Saiki A, Endo K, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohhira M, Oyama T, Miyashita Y, Shirai K.
    J Atheroscler Thromb; 2009 Oct 01; 16(5):568-75. PubMed ID: 19749494
    [Abstract] [Full Text] [Related]

  • 14. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
    Honda M, Hayashi K, Matsuda H, Kubota E, Tokuyama H, Okubo K, Ozawa Y, Saruta T.
    Clin Sci (Lond); 2001 Oct 01; 101(4):421-7. PubMed ID: 11566080
    [Abstract] [Full Text] [Related]

  • 15. Role of membrane depolarization and T-type Ca2+ channels in angiotensin II and K+ stimulated aldosterone secretion.
    Lotshaw DP.
    Mol Cell Endocrinol; 2001 Apr 25; 175(1-2):157-71. PubMed ID: 11325526
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels.
    Tanaka H, Shigenobu K.
    Cardiovasc Drug Rev; 2002 Apr 25; 20(1):81-92. PubMed ID: 12070536
    [Abstract] [Full Text] [Related]

  • 19. Pathophysiological significance of T-type Ca2+ channels: T-type Ca2+ channels and drug development.
    Tanaka H, Shigenobu K.
    J Pharmacol Sci; 2005 Nov 25; 99(3):214-20. PubMed ID: 16293935
    [Abstract] [Full Text] [Related]

  • 20. Identification of R(-)-isomer of efonidipine as a selective blocker of T-type Ca2+ channels.
    Furukawa T, Miura R, Honda M, Kamiya N, Mori Y, Takeshita S, Isshiki T, Nukada T.
    Br J Pharmacol; 2004 Dec 25; 143(8):1050-7. PubMed ID: 15545287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.